The third annual NYC Health Hackathonbrought together nearly 200 students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus, and several local and national academic institutions, to develop high-tech healthcare innovations.
Diffuse Intrinsic Pontine Glioma (DIPG) is every parent’s worst nightmare: a rare and incurable type of brain cancer that affects young children. Dr. Mark Souweidane decided to make curing this cancer his “Holy Grail”—and his progress since then has been impressive.
The death rate of children whose mothers have died from breast or cervical cancer may be as high as 30 percent in some developing countries, according to a new paper published Nov. 1 in Cancer by Weill Cornell Medicine and NewYork-Presbyterian researchers.
By sabotaging one of the tuberculosis bacterium’s defenses against antibiotics, Weill Cornell Medicine investigators may have found a way to accelerate treatment for the disease and possibly overcome growing resistance to existing therapies.
A new method for testing urinary tract infections yields more information than what conventional methods can offer, according to new research from investigators at Weill Cornell Medicine, Cornell’s Meinig School of Biomedical Engineering and NewYork-Presbyterian.